All biological stages, from the presence of slight dysplasia to carcinoma can be seen in the intraductal papillary mucinous neoplasms (IPMN).
All biological stages, from the presence of slight dysplasia to carcinoma can be seen in the intraductal papillary mucinous neoplasms (IPMN).
As one of the few surgically curable pancreatic tumors, accurate preoperative prediction of malignancy remains one of the major issues in the optimal treatment of IPMNs, and it also influences the outcome of the resection.
Pancreatic Cancer - All About the Disease, its Diagnosis and Management
Pancreatic cancer often involves its exocrine part. It grows aggressively, and often detected late. Treatment options include surgery, radiation and chemotherapy.
Pancreatic cancer often involves its exocrine part. It grows aggressively, and often detected late. Treatment options include surgery, radiation and chemotherapy.
The pathological study revealed 12 malignant IPMNs and 8 benign IPMNs. The diameters of the cystic lesions and main pancreatic ducts (MPDs) were significantly larger in malignant IPMNs compared with those of the benign IPMNs. The combined-type IPMNs had a higher rate of malignancy than the other 2 types of IPMNs. Tumors with mural nodules and thick septa had a significantly higher incidence of malignancy than tumors without these features. Communication of side-branch IPMNs with the MPD was present in 9 cases at pathologic examination. Seven of them were identified from CTA and MPVR or CR images. From comparison with the pathological diagnosis, the sensitivity, specificity, and accuracy of MDCT in characterizing the malignancy of IPMN of the pancreas were determined to be 100%, 87.5%, and 95%, respectively.
MDCT with CTA and MPVR or CR techniques can elucidate the imaging features of IPMNs and help predict the malignancy of these tumors.
Patrick Swayze Loses Battle to Pancreatic Cancer
Veteran actor Patrick Swayze died of pancreatic cancer on Monday, aged 57.
Veteran actor Patrick Swayze died of pancreatic cancer on Monday, aged 57.
Source-Eurekalert
RAS
Pancreatic Tumor Aggressiveness can be Predicted by Blood-Flow Metabolism Mismatch
A blood-flow glucose consumption mismatch that predicted pancreatic tumor aggressiveness has been identified by researchers from Turku, Finland.
A blood-flow glucose consumption mismatch that predicted pancreatic tumor aggressiveness has been identified by researchers from Turku, Finland.
Pancreatic Cancer Affects Blacks at Higher Rates
Regardless of risk factors linked to pancreatic cancer, such as smoking and body mass index (BMI), blacks experienced higher rates of pancreatic cancer death than whites.
Regardless of risk factors linked to pancreatic cancer, such as smoking and body mass index (BMI), blacks experienced higher rates of pancreatic cancer death than whites.
